NeoGeneStar is an innovative New Jersey based biotechnology company. NeoGeneStar was founded in 2013 with a focus on advancing the methods for isolation of cell free nucleic acid used in liquid biopsy detection for early cancer detection and NIPT. We have also developed innovative high power magnets to work with our cell free DNA purification kits which also have applications in immunology and cell biology.
1) patented (10,619,152 & 10,844,369) cell free nucleic acid purification methods for cancer detection and NIPT
2) Patented magnetic hardware which simplify the cell free nucleic acid purification and also are useful for biomolecule purification such as proteins, antibodies, and cells.
Our customers include first-in-class US and International Cancer centers and Prenatal Genetic Testing Centers including:
National Institute of Health - NHGRI
John Hopkins Medical Center
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical School
MD Anderson Cancer Center
Dana Farber Cancer Center
Mt. Sinai School of Medicine
University of Trento, Italy
Cambridge University, UK
Mainz University, Germany
Candiolo Cancer Institute, Italy